Integra LifeSciences | IART - Zinsaufwendungen Für Schuld

Aktienkurs
9.91
Täglich Wechseln
0.08 0.81%
Monatlich
3.12%
Jährlich
-41.67%
Q2 Prognose
9.24




Zinsaufwendungen Für Schuld Veränderung Datum
Abbott USD 42M 2M 2025-12
AtriCure USD 1.33M 17K 2025-09
Baxter International USD 58M 14M 2025-09
Becton, Dickinson and Co. USD 153M 2M 2025-12
Boston Scientific USD 90M 3M 2025-12
CONMED USD 7.37M 236K 2025-12
Cooper Companies USD 22.4M 2M 2025-12
Dexcom USD 4.7M 0 2025-09
Edwards Lifesciences USD 38.6M 1.2M 2025-09
Globus Medical USD 17K 5.1B 2025-12
HeartBeam USD 744K 2K 2021-12
Hologic USD 27.6M 1000K 2025-12
Insulet USD 9.2M 2.2M 2025-12
Integra LifeSciences USD 23.67M 953K 2025-12
Intuitive Surgical USD 19.35B 811.4M 2025-09
J&J USD 18M 290M 2025-09
Medtronic USD 181M 0 2025-12
Merit Medical Systems USD 6.36M 390K 2025-12
Orthofix International 4.68M 731K 2025-09
Smith & Nephew USD 69M 1000K 2025-12
Stryker USD 157M 46.17B 2025-09
Tandem Diabetes Care USD 2.07M 872.58M 2025-12
Teleflex USD 28.15M 3.69M 2025-12
Zimmer Biomet Holdings USD 71.9M 3.5M 2025-12